newsfilter
← Latest News
Business Wire·

enGene to Participate in Upcoming Investor Conferences

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral gene therapy company, today announced that management will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare